CannabisNewsBreaks – Sugarmade Inc. (SGMD) Leveraging ‘Prime Spot’ for Expansion of Cannabis Delivery Business

Sugarmade (OTC: SGMD), an innovator in the dynamic California cannabis sector, is positioned for opportunity as states that have already legalized cannabis, such as California, are seeing a spike in business due to the overwhelming convenience of product delivery. Sugarmade, as an innovator in the dynamic California cannabis scene with majority control and ownership of cannabis delivery service Nug Avenue, provides hand-selected top-shelf products from Stiiizy, Kanha, PlugPlay, Cookies and more. “Earlier this year, Sugarmade acquired a 70% stake in Nug Avenue, a Lynwood, California-based cannabis delivery operation, and launched a new business initiative for the licensed delivery of cannabis products,” reads a recent article that quotes Sugarmade CEO Jimmy Chan on the move. “We strongly believe the LA delivery market is the prime spot for expansion of our business,” said Chan. “California is the world’s sixth-largest economy, and LA County is by far the most significant driver, with over 25% of the state’s population. The Lynwood, California, site is optimal, as it is located along one of the major distribution freeways, allowing drivers to efficiently reach the more than 15 million consumers that live within a 30-mile radius of the new location. We plan to make a big impact on the LA cannabis delivery marketplace.”

To view the full article, visit https://cnw.fm/IZrxZ

About Sugarmade Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush, NUG Avenue, Lemon Glow, and Budcars. For more information, please visit www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SGMD

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Sector Employs Thousands from Restaurant, Retail Segments

A report has found that about 320,000 Americans are working in the cannabis industry. This represents a more than 30% increase from 2020 figures, making cannabis one of the country’s fastest-growing sectors. This also means that the United States has more legal marijuana workers than electrical engineers, paramedics or dentists.

The marijuana industry has grown significantly since last year when cultivation facilities and dispensaries were classified as essential businesses by various states at the onset of the coronavirus pandemic.

Published in partnership with Whitney Economics, the Leafly Jobs Report shows that in 2020, the industry added about 80,000 jobs to the market, which is almost twice what it added in 2019. It helps that more states across the country are also legalizing the use of the plant for both recreational and medical purposes.

Some Americans are re-evaluating their career prospects and jobs after the pandemic remodeled their working and social lives. Many are quitting their jobs in search of more opportunities for advancement, better benefits and consistent hours, which can be found in the legal marijuana industry.

Viridian Staffing chief executive of cannabis recruiting Kara Bradford stated that a shift of workers from restaurants and retail to marijuana has been observed, noting that there’s a sense that the industry has a lot of opportunities for advancement. The surge in marijuana hiring has put pressure on other employers to ease drug-testing requirements, especially in the District and the eighteen states where recreational cannabis use is legal. This is in addition to increasing pay, as the hourly rate at dispensaries is between $12 and $15.

Earlier in June, the second-biggest private employer in the country, Amazon, announced that it would support federal measures to legalize cannabis and stop screening employees for marijuana use. Other employers, including city governments, restaurants and retailers, have also removed these requirements in an attempt to attract workers in the current labor market where employment opportunities exceed the number of unemployed Americans.

Workers’ rights groups are also calling for broader unionization in the marijuana industry, noting that it is a crucial time to establish well-paying jobs that have proper protections. They assert that the marijuana industry could become a pipeline to middle-class jobs, with the right policies.

Cowen, a Wall Street research firm, revealed that sales of legal marijuana grew to $19 billion in 2020, which equates to an almost 60% increase. By 2025, the industry’s sales are expected to hit $41 billion.

Those growing employment figures take on an added meaning when one considers the rate at which companies such as Hero Technologies Inc. (OTC: HENC) are expanding and taking on new employees.

NOTE TO INVESTORS: The latest news and updates relating to Hero Technologies Inc. (OTC: HENC) are available in the company’s newsroom at https://cnw.fm/HENC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Researchers Investigate Whether CBD May Help Treat Oral Ulcers

Ever since the 2018 Farm Bill legalized the cultivation and sale of industrial hemp and its derivatives, the demand for cannabidiol (“CBD”), a hemp extract claimed to be full of potent medicinal properties, has skyrocketed. Plenty of people around the country have been using CBD to alleviate a wide variety of health issues including pain, anxiety, and skin conditions such as acne and psoriasis, among others. As the nascent CBD industry grows every year, scientists around the world have been avidly studying the cannabinoid to see just how much medical potential it holds.

recent study by researchers from Sichuan University’s West China Hospital of Stomatology has revealed that thanks to its potent anti-inflammatory properties, CBD may be able to alleviate the pain associated with oral ulcers as well as increase the rate of healing. Presented at the 99th General Session & Exhibition of the International Association for Dental Research, the study utilized mouse models depicting oral ulcers created by mechanical trauma or acid etching in the mouths of the laboratory mice.

After the researchers applied an oral spray containing CBD and ran histological and macroscopic evaluations, they found that cannabidiol was quite capable of treating the pain triggered by the inflammation caused by the ulcers. Applying the cannabidiol oral spray topically to the ulcers in a dose-dependent way resulted in faster wound closure and eliminated the possibility of weight loss.

Xingying Qi, the lead study author says the application of a cannabidiol oral spray led to a significant reduction in inflammation and pain, as well as expedited lesion closure. Although oral ulcers are a common oral inflammatory lesion that can cause severe pain, few effective treatment options are available. The results of this Chinese study indicate that cannabidiol represents a potential treatment for oral ulcers.

Curious to see how CBD alleviated oral ulcer symptoms, the researchers delved even deeper. After analyzing published datasets showing RNA-sequences linked to recurrent aphthous ulcers, they found that high NLPR3 expression, which plays a major role in inflammation and the body’s immune system, was a likely contributory factor in the onset of recurrent aphthous ulcers. Their research revealed that “cannabidiol significantly deactivates NLRP3 inflammasome expression” and may inhibit inflammasome-related pyroptosis, making it quite helpful in oral ulcer treatment.

The researchers also noted that cannabidiol reduced the activation of CMPK2, an enzyme that controls mitochondrial DNA synthesis, in turn reducing the synthesis of new mitochondrial DNA and suppressing the activation of inflammasome. The results of the Sichuan University study were published in the “Journal of Dental Research.

There is much yet to be known about the therapeutic properties of CBD, but the fact that many companies, including Simply Sonoma Inc., are thriving as manufacturers of CBD medicinals means that consumers may intuitively be aware of the numerous benefits such protects have.

NOTE TO INVESTORS: The latest news and updates relating to Simply Sonoma Inc. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – American Cannabis Partners Stands Distinct with Emphasis on Assets and Safety

American Cannabis Partners (“ACP”), a sustainable Jamaican experience canna-business innovator, is a company worth watching as it expands across the U.S. and maintains its status as a high-quality grower while remaining environmentally friendly and implementing its asset and safety strategy. Under the strategy, tangible assets like real estate and equipment play a key role in creating stability for ACP before building the company out. It also enables the company to capitalize on federal interstate commerce opportunities. “[ACP has] acquired 11 cultivation licenses, one retail license and around 560,000 square feet of canopy space for cultivation. This provides the safety net to liquidate if necessary to stay in business while also protecting shareholders. ACP will remain cash flow positive as they move forward into their projected third U.S. state in 2022 and a fourth in 2024,” reads a recent article. The concern for safety highlights the company’s distinction. According to CEO Stephen Jordan, the company’s emphasis on assets and safety is one of the hardest things to find in the industry. “A lot of people and a lot of companies have products, but they’ve placed themselves in very strenuous liability situations. If they can’t make a product, they no longer have a company. ACP took the opposite direction.”

To view the full article, visit https://cnw.fm/VW8Wj

About American Cannabis Partners

American Cannabis Partners is a fully licensed, large scale and 100% organic cannabis cultivation company nationally headquartered in Trinity County of the Emerald Triangle. Guided by business professionals and cultivators, the company focuses on four industry segments: real estate, cultivation, medical research, and nonprofit groups. For both medical and recreational, American Cannabis Partners supplies multiple forms of raw product at wholesale prices for manufacturing, distribution and retail licenses. Its commodity pricing model enables stable profit margins for customers, aiding the company’s expansion into multiple states. For more information, visit the company’s website at www.ACPFarms.com.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Simply Sonoma Committed to Becoming Leader in Plant-Based Medicinal Health, Beauty Products

Simply Sonoma is a different kind of natural CBD company looking forward to introducing its exceptional products to the consumer market. With recent research indicating that more than 53% of consumers are willing to pay more for organic cannabis products, Simply Sonoma appears to be perfectly positioned as an organic product company in every sense. “From seed to sale, the company owns or contracts the organic grow, extraction and product formulation operations, ensuring the quality and sustainability of the entire process,” reads a recent article. “Simply Sonoma is committed to building a reputation for being a leader in plant-based medicinal health and beauty products. As part of that commitment, the company is focused on developing broad-spectrum CBD products for therapeutic applications from a scientific perspective. Its products come from the farm rather than from a lab, with the goal of achieving fewer side effects and more efficacy for patients. Simply Sonoma also partners exclusively with organizations that share its focus; the company is committed to only collaborating with enterprises that are environmentally conscious, solar first and organic-equivalent.”

To view the full article, visit https://cnw.fm/LJfup

About Simply Sonoma

Simply Sonoma strives to deliver plant-based, broad-spectrum CBD products for therapeutic applications from a scientific perspective. Its products are derived from a farm rather than from a lab, with the goal of achieving fewer side effects and more efficacy for patients. Simply Sonoma believes in published, science-based trials and research with regards to its CBD creations. The company’s plants are grown organically in Sonoma County’s wine country, where sustainable farming practices are employed throughout the growing process. Solar energy helps the company to operate with a minimal carbon footprint. Simply Sonoma’s dynamic team consists of seasoned professionals from a combination of industries. Their broad experience stems from the biotech industry, grape and hemp cultivation, IT operations and communications, as well as executive positions in the health care sector. This unique combination of experience places the team well in the CBD space to dominate with wellness and lifestyle products. Simply Sonoma is focused on being a leader in the industry for plant-based, organic medicinal health and beauty products and partnering with like-minded companies to produce top-notch products. For more information, visit the company’s website at www.SimplySonoma.org.

NOTE TO INVESTORS: The latest news and updates relating to Sonoma are available in the company’s newsroom at https://cnw.fm/Sonoma

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Begins Phase 2 Clinical Trial Evaluating CBN in the EB Treatment

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has started its Phase 2 clinical trial of INM-755 (cannabinol) cream in the treatment of epidermolysis bullosa (“EB”). According to the company, this is the first time cannabinol has advanced to a Phase 2 clinical trial to be studied as a therapeutic option to treat a disease. The study will be conducted in seven different countries at 11 sites; the countries include Austria, Germany, Greece, France, Italy, Israel and Serbia. The company has filed clinical trial applications in all seven countries and has received approval from Austria, France, Greece and Israel, with the first site initiation visit being completed at a clinical site in Austria. Screening for eligible participants is set to begin in Austria soon. INM-755 is a cannabinol cream being considered as a topical therapy to treat EB and potentially other dermatological diseases. Currently EB has very few treatment options. “The achievement of this important milestone along the continuum of pharmaceutical drug development in EB supports our belief that this class of compounds hold broad therapeutic potential,” said InMed president and CEO Eric A. Adams in the press release. “This study further demonstrates InMed’s leadership in the development of rare cannabinoids as therapeutic products. In addition, we look forward to achieving key milestones of our second CBN drug candidate for the treatment of glaucoma in the year ahead.”

To view the full press releases, visit https://ibn.fm/ZlNjl

About InMed Pharmaceuticals Inc.

InMed Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (“CBN”); the company is developing IntegraSyn(TM) to produce pharmaceutical-grade cannabinoids. INM is dedicated to delivering new therapeutic alternatives to patients who may benefit from cannabinoid-based medicines. For more information, please visit www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Growing Numbers of Menopausal Women Resort to Cannabis for Symptomatic Relief

Between the ages of 45 to 55, most women will experience menopause as their estrogen levels steadily decline. One in 100 women will start going through this inevitable stage of life before they hit age 40. Regardless of when menopause starts, the symptoms associated with it are similar across the board. They include irregular periods, chills, hot flashes, night sweats, sleep problems, mood changes and weight gain among others.

Although some medications are proven to help women weather these symptoms, an increasing number of women have been turning to cannabis for this purpose. According to a new study, a “good number” of midlife women have been using the controversial plant, believing that it will help to treat some of the more uncomfortable menopause symptoms. Katherine Babyn, lead researcher and a graduate student at the University of Alberta in Canada, says that plenty of middle-aged women in the menopause transition period of their lives are using cannabis to alleviate symptoms that “tend to overlap with menopause.”

But can cannabis actually help women deal with these symptoms? Dr. Stephanie Faubion, medical director of the North American Menopause Society (“NAMS”), says that unfortunately, there is minimal scientific evidence proving that cannabis can effectively treat menopause-related symptoms. Since marijuana’s effect on women going through menopause hasn’t been formally studied, she says, we do not know the possible benefits and risks. Consequently, women who are using cannabis to alleviate their symptoms are essentially using a drug that has not been studied.

However, the study revealed that plenty of middle-aged women feel like they have benefited from using cannabis. The researchers from the University of Alberta surveyed an estimated 1,500 middle-aged women from the province of Alberta in Canada and found that two-thirds of the respondents had used cannabis for some time, with one-third having done so within the past month. Of the women who were currently using cannabis, 75% said they were using it for medical purposes. This is despite the fact that only 23% actually had medical marijuana prescriptions.

In addition, the study reported that 52% consumed edibles, 47% used cannabis oils, 41% preferred to smoke, and 26% vaped. Up to 74% of the respondents said their symptoms had improved once they started using cannabis, says Nese Yuksel, senior researcher and a professor of pharmacy and pharmaceutical sciences at the University of Alberta. Other noteworthy stats include 74% of respondents reported using cannabis to sleep better, 59% used it for anxiety, 58% to boost concentration, 55% to reduce feelings of irritability, and 53% to alleviate muscle and joint aches.

Still, Yuksel says that without any scientific backing, the researchers cannot make an association between cannabis use and reduced menopause symptoms. Although the women may feel as if they’re seeing some benefit from consuming cannabis, she says, the researchers cannot conclusively say that the drug can treat menopause symptoms. Ultimately, they all agreed that we need more research on marijuana’s potential benefits and risks to see whether or not it can be an effective treatment for menopause symptoms.

Companies that manufacture a variety of CBD products, such as The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER), may inadvertently be helping menopausal women if some of the preliminary studies on cannabidiol, a major compound in cannabis, are anything to go by.

NOTE TO INVESTORS: The latest news and updates relating to The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) are available in the company’s newsroom at http://cnw.fm/WTER

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Amazon Voices Support for Federal Cannabis Legalization, Ends Employee Drug Testing

Amazon recently let up on its screening policies for cannabis, with company officials vocalizing their support for the federal legalization of the plant. Beth Galetti, who is the company’s HR boss, stated that the company had restored employment eligibility for applicants and past employees who had been denied employment or fired during cannabis screenings.

Galetti added that pre-employment cannabis testing had disproportionately impacted communities of color by impeding job placement and, by extension, the growth of the economy. She noted that this inequitable treatment was unacceptable.

Earlier in June, company officials stated that they would no longer screen their workers for cannabis. This is excluding job candidates who are applying for positions that involve the operation of heavy equipment or truck drivers, as those positions are regulated by the federal Department of Transportation.

Amazon also revealed that following an incident, it would continue to conduct tests for alcohol and drugs and impairment checks on the job.

The international e-commerce company decided to let up on its cannabis standards after a growing number of states in the U.S. began legalizing the plant. Galetti notes that the loosened standards are expected to bring more job applicants into the company.

Thus far, marijuana has been legalized for recreational use in 18 states as well as in Guam, the Northern Mariana Islands and the District of Columbia. Medical marijuana is also legal in 36 states across the United States, as well as in the Virgin Islands, Puerto Rico, Guam and the District of Columbia.

In addition to this, Galleti stated that the company’s pace of growth meant that it was always in search of new members to add to its team. Recently Amazon has been using various incentives, including free college tuition and hiring bonuses, in an attempt to attract more applicants. Now company officials have announced plans to removing pre-employment testing for marijuana, which would allow the company to extend its applicant pool.

The trillion-dollar company is also calling for the federal government to legalize cannabis, with company officials revealing that they support the Marijuana Opportunity Reinvestment and Expungement (“MORE”) Act. The objective of the act is to invest in communities that have been affected by the drug war, expunge criminal records for those incarcerated for possession and decriminalize marijuana at the federal level.

Recently, Amazon threw its weight behind similar legislation dubbed the Cannabis Administration and Opportunity Act. In a letter addressed to legislators about this measure, the renowned company urged Congress to allow for resentencing of any individuals serving time in federal prison for nonviolent cannabis crimes and expungement of the records for those crimes.

The increasing use of cannabis as a medicinal substance is causing a spike in the demand for IoT dose-measuring devices such as the ones made by RYAH Group Inc. (CSE: RYAH) alongside other enabling technologies.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) TRACE Product Line Named as Official Water Supplier of Canadian E-Fest

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has announced that its market-leading TRACE line of natural alkaline spring waters will be the official water supplier of the Canadian E-Prix/2022 Vancouver E-Prix event. This includes the highly anticipated Formula E electric car race, part of the ABB FIA Formula E World Championship series. The three-day Canadian E-Fest will welcome the ABB FIA Formula E World Championship and also offer plenty of action off-track beginning with a creative business conference on sustainability. Taking place on June 30 – July 2, 2022, the festival will feature a fan village, concerts by two top Canadian musical artists and the Formula E electric car race, the pinnacle of the event, to be held on July 2 in Vancouver’s False Creek. “BevCanna and TRACE are a perfect fit for Canadian E-Fest/Vancouver E-Prix’s commitment to sustainability,” said Matthew Carter, president and CEO, OSS Group. “As a local B.C. water company, bottling high-quality natural waters sourced from a B.C. aquifer, in fully recyclable containers, TRACE was a natural choice to be our water supplier.”

To view the full press release, visit https://cnw.fm/C5Ts1

About BevCanna Enterprises Inc.

BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, Canada, BevCanna owns a pristine alkaline spring water aquifer and a world–class 40,000–square–foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210M bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with #1 U.S. cannabis beverage company Keef Brands. For more information about the company, visit www.BevCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://cnw.fm/BVNNF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – USA CBD Expo to Shine the Spotlight on Industry’s Leading Professionals, Latest Trends

The next USA CDB Expo will be hosted at Chicago’s McCormick Place on Oct. 28-30, 2021. Following June’s Atlanta-based conference and its successful return to an in-person format, the nation’s largest CBD event series will continue with a three-day event in the Midwest that provides industry enthusiasts the opportunity to glean insight from more than 50 expert speakers, visit with hundreds of vendors and network with thousands of their peers. Presenting sponsor 3Chi, the nation’s largest CBN and Delta-8 distributor, is headlining October’s USA CBD Expo. The event represents an early celebration of the state’s second anniversary of the legalization of recreational consumption, possession and sale of cannabis products in Illinois. Within a short timeframe, Illinois’ recreational cannabis sector has grown to an estimated $40 million per month in retail revenues, a clear testament to the industry’s positive potential and growth trajectory. Designed to cater to industry newcomers and experts alike, the conference will feature some of the CBD and hemp industry’s leading professionals presenting a series of educational seminars, keynote addresses and workshops. Seminars will cover a range of topics, including a focus on the commercial side of the CBD and hemp industry, current and future market trends, health benefits, ongoing legalization efforts, as well as medicinal use cases. In addition, some of the scheduled talks include CBD for sexual wellness, the power of medicinal mushroom extracts, psychedelics education, information about delta-8 and its legality, and other diverse topics.

To view the full press release, visit https://cnw.fm/4dkZ1

About USA CBD Expo

USA CBD Expo strives to create the best and largest CBD/hemp event in the nation, to consistently bring the most innovative and best products/brands to businesses and consumers, to compress a rapidly expanding industry into one all-encompassing, premier event. The team is committed to representing unrivaled passion through its events and is dedicated to presenting the benefits of CBD, a product it truly believes in. Buyers, businesses and consumers will find everything they need at USA CBD Expo shows. With 300+ vendors, the right product, the right brand and the right deal will be available all at once, only at the nation’s largest CBD event. For more information, visit www.USACBDExpo.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.